Cleared Traditional

K780015 - THYROID STIMULATING HORMONE

K780015 is the FDA 510(k) clearance for THYROID STIMULATING HORMONE by Pcl-Ria, Inc.. It is a Class 2 Immunology device (product code JLW) cleared through the Traditional 510(k) pathway after a 35-day FDA review.

K780015 · Pcl-Ria, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1978
Decision
35d
Days
Class 2
Risk

K780015 is an FDA 510(k) clearance for the THYROID STIMULATING HORMONE. Classified as Radioimmunoassay, Thyroid-stimulating Hormone (product code JLW), Class II - Special Controls.

Submitted by Pcl-Ria, Inc. (Mchenry, US). The FDA issued a Cleared decision on February 7, 1978 after a review of 35 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 862.1690 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Pcl-Ria, Inc. devices

Submission Details

510(k) Number K780015 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 03, 1978
Decision Date February 07, 1978
Days to Decision 35 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
69d faster than avg
Panel avg: 104d · This submission: 35d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JLW Radioimmunoassay, Thyroid-stimulating Hormone
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1690
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - JLW Radioimmunoassay, Thyroid-stimulating Hormone

All 154
Devices cleared under the same product code (JLW) and FDA review panel - the closest regulatory comparables to K780015.
TSH RIA KIT
K780726 · Amersham Corp. · Jun 1978
ROCHE TSH RIA
K780428 · Hoffmann-La Roche, Inc. · Mar 1978
RABBIT ANTIBODY/THYROID STIMUL. HORMONE
K780059 · Pcl-Ria, Inc. · Feb 1978
NEONATAL TSH RIA KIT (125I)
K772192 · Diagnostic Products Corp. · Jan 1978
SERALUTE TSH (RIA)
K771767 · Miles Laboratories, Inc. · Oct 1977
TSH RIA REAGENT SET
K771234 · G.D. Searle and Co. · Oct 1977